Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effects of Using Yupingfeng Powder With Variation for the Treatment of Allergic Rhinitis (AR): a Randomized Controlled Trial

NCT06608017 is registered in ClinicalTrials.gov with Chinese University of Hong Kong as lead sponsor.

NCT NCT06608017
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06608017 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effects of Using Yupingfeng Powder With Variation for the Treatment of Allergic Rhinitis (AR): a Randomized Controlled Trial
Lead sponsor
Chinese University of Hong Kong
Phase
Phase 2/3
Overall status
Recruiting
Start date
March 27, 2025
Completion date
December 31, 2026
Enrollment
140 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

allergic rhinitis